In vitro study of ALS mouse model cells show that human bone marrow endothelial progenitor cells (hBMEPC) can increase VEGF-A and angiogenin-1 levels, differentiate into ECs, and express cell membrane proteins such as occluding and ZO-1. Here, VEGFA is linked to amyotrophic lateral sclerosis.